Prediction Case File
YouTubeEvaluation Complete

HEDERA HBAR PRICE PREDICTION 2025

1 extracted signal · 1 resolved · 0 still active

Cilinix Crypto profile imageCilinix Crypto24 Nov 2025, 15:45 UTC
Video preview for HEDERA HBAR PRICE PREDICTION 2025
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
0
Canonical correct result
Failed
1
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis focuses on HBAR/USDT. The current price is 0.1447. There's a critical support level between 0.13 and 0.15. The analyst highlights a bounce at this level. A reclaim of the 0.155 level is needed to potentially confirm a local bottom. With a target of 0.155, failure to hold support at 0.13 would invalidate a short term bullish outlook. The analyst suggest that it is likely that it will consolidate between 0.155 and 0.13, and need to get some sort of strong reaction . They also point out that intraday support level and value gap is around 0.14.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Cilinix Crypto

Tracked signals
1195
Historical success
42.8%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.